P30 Administrative Supplement COE Cancer Controls: Increasing Tobacco and Lung Cancer Screening through patient Navigation

P30 行政补充 COE 癌症控制：通过患者导航增加烟草和肺癌筛查

• 批准号: 10407827
• 负责人: KEVIN J. CULLEN
• 金额: $ 34.13万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-08-08 至 2026-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10407827
• 关键词: Address; Administrative Supplement; Adoption; Adult; Advisory Committees; American Cancer Society; Area; Baltimore; Bronchi; Cancer Burden; Cancer Control; Cancer Patient; Cancer Survivor; Cancer Survivorship; Capital; Catchment Area; Centers for Disease Control and Prevention (U.S.); Cessation of life; Cities; Collaborations; Communication; Communication Methods; Community Outreach; Comprehensive Cancer Center; Counseling; County; Data; Data Collection; Evaluation; Evidence based intervention; Goals; Grant; Health; Health Personnel; Individual; Intervention; Leadership; Life Expectancy; Lung; Malignant Neoplasms; Malignant neoplasm of lung; Maryland; Mediating; Medical; Methods; National Cancer Institute; Operative Surgical Procedures; Patient Education; Patients; Persons; Pharmaceutical Preparations; Prevention; Preventive service; Publishing; Radiation therapy; Reach, Effectiveness, Adoption, Implementation, and Maintenance; Recommendation; Resources; Risk; Site; Smoke; Smoker; Smoking History; Structure; Target Populations; Text; Time; Tobacco; Tobacco Use Cessation; Training; United States; Universities; Work; X-Ray Computed Tomography; aged; base; cancer risk; chemotherapy; cigarette smoking; community engagement; computed tomography screening; environmental tobacco smoke; falls; high risk; implementation outcomes; low dose computed tomography; lung cancer screening; neoplasm registry; nicotine replacement; programs; quitline; ranpirnase; reduce tobacco use; routine screening; screening; screening services; smoking cessation; targeted treatment; tobacco cessation intervention; tool; willingness

Project Summary/Abstract: There is a critical need to assist Marylanders navigate through treatment options related to tobacco cessation and lung cancer screening. The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) senior leadership, including its director, Dr. Kevin Cullen, strongly support the idea of establishing an organized approach to tobacco cessation and lung cancer screening in Maryland. This project works to increase lung cancer screening using low-dose CT scan to eligible adults from UMGCCC’s catchment area. UMGCCC’s catchment area serves 5.4 million Marylanders living in a 10-county region of central Maryland. The area surrounds UMGCCC in Baltimore City, includes the Baltimore-DC corridor, and the Maryland State capital of Annapolis The proposed work will form a partnership between the UMGCCC’s Office of Community Outreach and Engagement, the Maryland Cancer Collaborative, and the Maryland Patient Navigator Network (PNN). The project will provide training to the PNN of 282 patient navigators to utilize communication, tobacco cessation, and LDCT screening strategies. This will increase referrals to the Maryland Quitline and refer eligible individuals to lung cancer screening services. This work aims to increase the proportion of high-risk adults (50-80 years old with a 20-pack-year history of smoking or those who quit within the last 15 years) screened for lung cancer and support and to implement CDC- recommended evidence-based interventions that reduce tobacco use and increase the demand for cessation. The lung cancer screening rate currently site at 8.3% in Maryland. Our goal is to utilize the trained patient navigators to help refer eligible Marylanders to get screened and increase this percentage to 16.8% This can happen if the 282 Patient Navigators refer and average of 10 eligible Marylanders. Patient Navigators can also amplify the tobacco cessation messaging utilizing CDC recommended evidence-based interventions. Evaluation will be guided by the RE-AIM Framework, with a focus on adoption, reach, and implementation. The Quitline and LDCT interventions are evidence-based with the emphasis falling on implementation outcomes. The project will be sustained after the grant period ends through Comprehensive Cancer Control Coalition patient navigator structures and evaluation activities, as well as through UMGCCC Community Outreach and Engagement data collection activities.

项目摘要/摘要： 迫切需要帮助马里兰人了解与烟草相关的治疗方案 马里兰大学格林鲍姆综合戒烟和肺癌筛查。 癌症中心 (UMGCCC) 高层领导，包括其主任 Kevin Cullen 博士的大力支持 建立有组织的戒烟和肺癌筛查方法的想法 马里兰州该项目致力于使用低剂量 CT 扫描增加对符合条件的肺癌筛查。 UMGCCC 服务范围内的成年人为 540 万人口提供服务。 居住在马里兰州中部 10 个县地区的马里兰人，该地区围绕 UMGCCC。 巴尔的摩市，包括巴尔的摩-华盛顿走廊和马里兰州首府安纳波利斯 拟议的工作将在 UMGCCC 社区办公室之间建立伙伴关系 外展和参与、马里兰州癌症合作组织和马里兰州患者导航员 该项目将为 282 名患者导航员提供培训以利用 PNN。 沟通、戒烟和 LDCT 筛查策略这将增加转介到该机构的人数。 马里兰州戒烟热线并将符合条件的个人转介至肺癌筛查服务。 增加高危成人（50-80岁，有20包年吸烟史或 过去 15 年内戒烟的人）进行肺癌筛查和支持，并实施 CDC- 建议采取基于证据的干预措施，减少烟草使用并增加对烟草的需求 停止。 马里兰州目前的肺癌筛查率为 8.3% 我们的目标是利用。 训练有素的患者导航员帮助转介符合条件的马里兰人接受筛查并增加 该百分比为 16.8% 如果 282 名患者导航员推荐且平均值为 10，则可能会发生这种情况 符合条件的马里兰州患者导航员还可以扩大戒烟信息。 CDC 利用推荐的循证干预措施。 评估将以 RE-AIM 框架为指导，重点关注采用、覆盖范围、 戒烟热线和 LDCT 干预措施是基于证据的。 拨款后，该项目将继续重视实施成果。 通过综合癌症控制联盟患者导航器结构和 评估活动，以及通过 UMGCCC 社区外展和参与数据 征集活动。